PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Amitriptyline hydrochloride - Pain (Neuropathic)

PAD Profile : Amitriptyline hydrochloride - Pain (Neuropathic)

Keywords :
neuropathic pain, diabetic neuropathy, postherpetic neuralgia, PHN, Tricyclic antidepressants, TCAs, tricyclics
Brand Names Include :
Triptafen

Traffic Light Status

Status 1 of 1.

Status :
Green
Preferred
Formulations :
  • Oral solution
  • Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
07 October 2020
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

Amitriptyline or duloxetine are recommended as a teatment option at step 1 of the local neuropathic pain guidelines.
See guidelines below.

Associated BNF Codes

04. Central Nervous System
04.07.03. Neuropathic pain
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More